CCL INDUSTRIES INC - CL B (CCL-B.CA) Stock Fundamental Analysis
TSX:CCL-B - Toronto Stock Exchange - CA1249003098 - Common Stock - Currency: CAD
CCL-B gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 8 industry peers in the Containers & Packaging industry. CCL-B scores excellent on profitability, but there are some minor concerns on its financial health. While showing a medium growth rate, CCL-B is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year CCL-B was profitable.
In the past year CCL-B had a positive cash flow from operations.
CCL-B had positive earnings in each of the past 5 years.
In the past 5 years CCL-B always reported a positive cash flow from operatings.
1.2 Ratios
CCL-B has a better Return On Assets (8.55%) than 75.00% of its industry peers.
CCL-B's Return On Equity of 15.97% is amongst the best of the industry. CCL-B outperforms 87.50% of its industry peers.
CCL-B's Return On Invested Capital of 9.60% is fine compared to the rest of the industry. CCL-B outperforms 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CCL-B is in line with the industry average of 9.12%.
The 3 year average ROIC (9.32%) for CCL-B is below the current ROIC(9.60%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.55% | ||
| ROE | 15.97% | ||
| ROIC | 9.6% |
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
1.3 Margins
CCL-B has a better Profit Margin (11.64%) than 87.50% of its industry peers.
CCL-B's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 14.70%, CCL-B belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
In the last couple of years the Operating Margin of CCL-B has remained more or less at the same level.
Looking at the Gross Margin, with a value of 29.51%, CCL-B is in line with its industry, outperforming 50.00% of the companies in the same industry.
CCL-B's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.7% | ||
| PM (TTM) | 11.64% | ||
| GM | 29.51% |
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
2. Health
2.1 Basic Checks
CCL-B has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CCL-B has less shares outstanding
CCL-B has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CCL-B has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.65 indicates that CCL-B is not in any danger for bankruptcy at the moment.
The Altman-Z score of CCL-B (3.65) is comparable to the rest of the industry.
The Debt to FCF ratio of CCL-B is 4.07, which is a neutral value as it means it would take CCL-B, 4.07 years of fcf income to pay off all of its debts.
CCL-B's Debt to FCF ratio of 4.07 is on the low side compared to the rest of the industry. CCL-B is outperformed by 62.50% of its industry peers.
CCL-B has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
CCL-B has a Debt to Equity ratio of 0.45. This is in the lower half of the industry: CCL-B underperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.07 | ||
| Altman-Z | 3.65 |
ROIC/WACC1.37
WACC7%
2.3 Liquidity
A Current Ratio of 2.01 indicates that CCL-B has no problem at all paying its short term obligations.
CCL-B has a better Current ratio (2.01) than 62.50% of its industry peers.
A Quick Ratio of 1.47 indicates that CCL-B should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.47, CCL-B is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.47 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 58.63% over the past year.
The Earnings Per Share has been growing by 12.06% on average over the past years. This is quite good.
Looking at the last year, CCL-B shows a quite strong growth in Revenue. The Revenue has grown by 8.95% in the last year.
CCL-B shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.37% yearly.
EPS 1Y (TTM)58.63%
EPS 3Y12.4%
EPS 5Y12.06%
EPS Q2Q%379.16%
Revenue 1Y (TTM)8.95%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%9.02%
3.2 Future
Based on estimates for the next years, CCL-B will show a small growth in Earnings Per Share. The EPS will grow by 6.39% on average per year.
Based on estimates for the next years, CCL-B will show a small growth in Revenue. The Revenue will grow by 4.39% on average per year.
EPS Next Y4.67%
EPS Next 2Y6.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.25%
Revenue Next 2Y4.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 15.92, CCL-B is valued correctly.
Based on the Price/Earnings ratio, CCL-B is valued a bit more expensive than 62.50% of the companies in the same industry.
When comparing the Price/Earnings ratio of CCL-B to the average of the S&P500 Index (29.35), we can say CCL-B is valued slightly cheaper.
A Price/Forward Earnings ratio of 15.97 indicates a correct valuation of CCL-B.
Based on the Price/Forward Earnings ratio, CCL-B is valued a bit more expensive than 62.50% of the companies in the same industry.
CCL-B's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.92 | ||
| Fwd PE | 15.97 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CCL-B is valued a bit more expensive than 75.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CCL-B is valued a bit more expensive than 62.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.94 | ||
| EV/EBITDA | 9.9 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCL-B does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of CCL-B may justify a higher PE ratio.
PEG (NY)3.41
PEG (5Y)1.32
EPS Next 2Y6.39%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CCL-B has a Yearly Dividend Yield of 1.78%.
Compared to an average industry Dividend Yield of 3.51, CCL-B has a dividend in line with its industry peers.
CCL-B's Dividend Yield is slightly below the S&P500 average, which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.78% |
5.2 History
On average, the dividend of CCL-B grows each year by 11.36%, which is quite nice.
CCL-B has paid a dividend for at least 10 years, which is a reliable track record.
CCL-B has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.36%
Div Incr Years23
Div Non Decr Years34
5.3 Sustainability
24.48% of the earnings are spent on dividend by CCL-B. This is a low number and sustainable payout ratio.
CCL-B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP24.48%
EPS Next 2Y6.39%
EPS Next 3YN/A
TSX:CCL-B (3/7/2025, 7:00:00 PM)
74.82
+2.73 (+3.79%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)
Earnings (Next)
Inst Owners40.46%
Inst Owner ChangeN/A
Ins Owners3.79%
Ins Owner ChangeN/A
Market Cap13.20B
Analysts82.11
Price Target92.62 (23.79%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.78% |
Yearly Dividend1.16
Dividend Growth(5Y)11.36%
DP24.48%
Div Incr Years23
Div Non Decr Years34
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-1.87%
Max Revenue beat(2)-0.25%
Revenue beat(4)1
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)1.57%
Revenue beat(8)1
Avg Revenue beat(8)-1.92%
Revenue beat(12)3
Avg Revenue beat(12)-1.65%
Revenue beat(16)6
Avg Revenue beat(16)-1.17%
PT rev (1m)1%
PT rev (3m)1.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)-0.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.71%
Revenue NY rev (3m)0.78%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.92 | ||
| Fwd PE | 15.97 | ||
| P/S | 1.82 | ||
| P/FCF | 21.94 | ||
| P/OCF | 12.41 | ||
| P/B | 2.5 | ||
| P/tB | 8.17 | ||
| EV/EBITDA | 9.9 |
EPS(TTM)4.7
EY6.28%
EPS(NY)4.69
Fwd EY6.26%
FCF(TTM)3.41
FCFY4.56%
OCF(TTM)6.03
OCFY8.06%
SpS41.05
BVpS29.92
TBVpS9.16
PEG (NY)3.41
PEG (5Y)1.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.55% | ||
| ROE | 15.97% | ||
| ROCE | 12.75% | ||
| ROIC | 9.6% | ||
| ROICexc | 10.66% | ||
| ROICexgc | 20.78% | ||
| OM | 14.7% | ||
| PM (TTM) | 11.64% | ||
| GM | 29.51% | ||
| FCFM | 8.31% |
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
ROICexc(3y)10.42%
ROICexc(5y)10.66%
ROICexgc(3y)20.67%
ROICexgc(5y)21.9%
ROCE(3y)12.39%
ROCE(5y)12.67%
ROICexcg growth 3Y-4.22%
ROICexcg growth 5Y-2.39%
ROICexc growth 3Y-1.48%
ROICexc growth 5Y-0.08%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
F-Score8
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.07 | ||
| Debt/EBITDA | 1.6 | ||
| Cap/Depr | 106.85% | ||
| Cap/Sales | 6.38% | ||
| Interest Coverage | 18.55 | ||
| Cash Conversion | 71.06% | ||
| Profit Quality | 71.39% | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.47 | ||
| Altman-Z | 3.65 |
F-Score8
WACC7%
ROIC/WACC1.37
Cap/Depr(3y)114.57%
Cap/Depr(5y)103.99%
Cap/Sales(3y)6.78%
Cap/Sales(5y)6.27%
Profit Quality(3y)87.06%
Profit Quality(5y)92.08%
High Growth Momentum
Growth
EPS 1Y (TTM)58.63%
EPS 3Y12.4%
EPS 5Y12.06%
EPS Q2Q%379.16%
EPS Next Y4.67%
EPS Next 2Y6.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.95%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%9.02%
Revenue Next Year5.25%
Revenue Next 2Y4.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.63%
EBIT growth 3Y8.62%
EBIT growth 5Y7.62%
EBIT Next Year39.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y11.11%
FCF growth 3Y5.34%
FCF growth 5Y6.76%
OCF growth 1Y6.04%
OCF growth 3Y8.25%
OCF growth 5Y6.42%